| Company Name: |
Capot Chemical Co.,Ltd. |
| Tel: |
571-85586718 +8613336195806 |
| Email: |
sales@capotchem.com |
| Products Intro: |
Product Name:(3S,11aR)-N-[(2,4-Difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
CAS:1051375-10-0
Purity:98% Min. Package:1G;1KG;100KG
|
|
|
|
|
- Cabotegravir (GSK744, GSK1265744)
-
- $240.00 / 10g
-
2023-11-16
- CAS:1051375-10-0
- Min. Order: 10g
- Purity: 99% Purity (What/sapp: +86 18145728414)
- Supply Ability: 1000 Tons/Month
- SureCN82803
-
- $15.00 / 1KG
-
2021-07-02
- CAS:1051375-10-0
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
- Cabotegravir
-
- $20.00 / 1KG
-
2020-11-16
- CAS:1051375-10-0
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 1000KG
Related articles - How is GSK744 synthesised?
- GSK744 (Cabotegravir) is synthesised using Cabotegravir Pyridinone as a raw material through a series of chemical reactions.
- Dec 19，2023
|
| | Cabotegravir (GSK744, GSK1265744) Basic information |
| Product Name: | Cabotegravir (GSK744, GSK1265744) | | Synonyms: | GSK744;(3S,11aR)-N-[(2,4-Difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide;Cabotegravir (GSK744, GSK1265744);Cabotegravir Free Acid;Cyclic pyranopterin;SK744, GSK1265744;Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, (3S,11aR)-;S/GSK1265744 | | CAS: | 1051375-10-0 | | MF: | C19H17F2N3O5 | | MW: | 405.35 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 1051375-10-0.mol |  |
| | Cabotegravir (GSK744, GSK1265744) Chemical Properties |
| Boiling point | 664.0±55.0 °C(Predicted) | | density | 1.57±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | insoluble in H2O; insoluble in EtOH; ≥19.35 mg/mL in DMSO with gentle warming | | form | solid | | pka | 4.50±1.00(Predicted) |
| | Cabotegravir (GSK744, GSK1265744) Usage And Synthesis |
| Uses | Cabotegravir is a long acting HIV-1 integrase inhibitor with action against a broad range of HIV subtypes. | | Definition | ChEBI: Cabotegravir is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of (3S,11aR)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid with the amino group of 2,4-difluorobenzylamine. Used (as its sodium salt) for treatment of HIV-1. It has a role as a HIV-1 integrase inhibitor. It is a difluorobenzene, a secondary carboxamide, a monocarboxylic acid amide and an organic heterotricyclic compound. It is a conjugate acid of a cabotegravir(1-). | | Biological Activity | Cabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor against a broad range of HIV subtypes, inhibiting HIV-1 integrase-catalyzed strand transfer with IC50 of 3 nM. Phase 2. | | Mechanism of action | Caboggravir is a potent inhibitor of HIV integrase, which prevents the HIV virus from infecting human cells, while rilpivirine prevents the virus from replicating itself. | | target | HIV integrase |
| | Cabotegravir (GSK744, GSK1265744) Preparation Products And Raw materials |
|